In Model 3, some adjusted variables were related to the comorbidities of obesity, abnormal liver function, hyperlipidaemia, and DM, such as body mass index, total bilirubin, direct bilirubin, TC, triglyceride, fast blood glucose, metformin, and SGLT2 inhibitor. This evidence concerns the gene SLC5A2 and Obesity.